BR0310003A - compostos peptìdeos e seu uso como substratos de protease - Google Patents

compostos peptìdeos e seu uso como substratos de protease

Info

Publication number
BR0310003A
BR0310003A BRPI0310003-0A BR0310003A BR0310003A BR 0310003 A BR0310003 A BR 0310003A BR 0310003 A BR0310003 A BR 0310003A BR 0310003 A BR0310003 A BR 0310003A
Authority
BR
Brazil
Prior art keywords
compounds
salts
protease
peptide compounds
substrates
Prior art date
Application number
BRPI0310003-0A
Other languages
English (en)
Inventor
Gary A Decrescenzo
Carol P Howard
Joseph G Rico
Kun Zhang
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of BR0310003A publication Critical patent/BR0310003A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSTOS PEPTìDICOS E SEU USO COMO SUBSTRATOS DE PROTEASE". Esta invenção refere-se geralmente a compostos peptídicos e sais, e particularmente a compostos peptídicos e sais que são úteis como substratos de protease, como substratos metaloprotease de matriz ('MMP'). Esta invenção refere-se também a métodos para preparação de tais compostos e sais, bem como a aminoácidos que podem, por exemplo, ser usados nesses métodos. Esta invenção refere-se ainda a métodos para uso de tais compostos e sais para, por exemplo, avaliar a eficácia dos inibidores potenciais de protease e para detectar ou monitorar uma doença associada com atividade de protease.
BRPI0310003-0A 2002-05-10 2003-05-10 compostos peptìdeos e seu uso como substratos de protease BR0310003A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37959802P 2002-05-10 2002-05-10
PCT/US2003/014869 WO2003095475A2 (en) 2002-05-10 2003-05-10 Peptide compounds and their use as protease substrates

Publications (1)

Publication Number Publication Date
BR0310003A true BR0310003A (pt) 2007-04-10

Family

ID=29420543

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0310003-0A BR0310003A (pt) 2002-05-10 2003-05-10 compostos peptìdeos e seu uso como substratos de protease

Country Status (11)

Country Link
US (1) US20040018561A1 (pt)
EP (1) EP1504094A2 (pt)
JP (1) JP2005538946A (pt)
KR (1) KR20050034642A (pt)
AU (1) AU2003263736A1 (pt)
BR (1) BR0310003A (pt)
CA (1) CA2485437A1 (pt)
IL (1) IL165084A0 (pt)
MX (1) MXPA04011142A (pt)
PL (1) PL374438A1 (pt)
WO (1) WO2003095475A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112840A2 (en) * 2003-06-25 2004-12-29 Guerbet Peptide conjugate for magnetic resonance imaging
US8968700B2 (en) * 2005-08-11 2015-03-03 The Board Of Trustees Of The Leland Stanford Junior University Imaging of protease activity in live cells using activity based probes
US11237171B2 (en) 2006-02-21 2022-02-01 Trustees Of Tufts College Methods and arrays for target analyte detection and determination of target analyte concentration in solution
US8492098B2 (en) 2006-02-21 2013-07-23 The Trustees Of Tufts College Methods and arrays for target analyte detection and determination of reaction components that affect a reaction
KR101016213B1 (ko) 2007-11-20 2011-02-25 한국과학기술연구원 단백질 분해효소의 영상화를 위한 소광된 형광 센서, 그제조 방법 및 용도
US8349580B2 (en) 2009-09-09 2013-01-08 3M Innovative Properties Company Methods and kit for protease enzyme assays
US8236574B2 (en) 2010-03-01 2012-08-07 Quanterix Corporation Ultra-sensitive detection of molecules or particles using beads or other capture objects
ES2544635T3 (es) 2010-03-01 2015-09-02 Quanterix Corporation Métodos para extender el rango dinámico en ensayos para la detección de moléculas o partículas
US9952237B2 (en) 2011-01-28 2018-04-24 Quanterix Corporation Systems, devices, and methods for ultra-sensitive detection of molecules or particles
US20140302532A1 (en) 2011-04-12 2014-10-09 Quanterix Corporation Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury
WO2014113502A1 (en) 2013-01-15 2014-07-24 Quanterix Corporation Detection of dna or rna using single molecule arrays and other techniques
US9141906B2 (en) * 2013-03-13 2015-09-22 Google Inc. Scoring concept terms using a deep network
WO2014147129A1 (en) 2013-03-21 2014-09-25 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
SG11201506804VA (en) 2013-03-21 2015-09-29 Sanofi Aventis Deutschland Synthesis of hydantoin containing peptide products
GB201504778D0 (en) 2015-03-20 2015-05-06 Univ Edinburgh Optical probes for matrix metalloproteinases
KR101989666B1 (ko) * 2017-03-24 2019-06-17 (주)셀아이콘랩 신규한 헵타펩타이드 단량체 및 이량체를 포함하는 피부노화 또는 피부주름 예방, 개선을 위한 화장료 조성물
KR102007078B1 (ko) * 2017-03-24 2019-08-05 (주)셀아이콘랩 콜라겐 생성을 촉진시키는 신규한 헵타펩타이드 단량체 및 이량체를 포함하는 피부 노화 방지를 위한 화장품 조성물
KR102007077B1 (ko) * 2017-03-24 2019-08-06 (주)셀아이콘랩 피부 노화 방지 및 피부 주름 예방용 펜타펩타이드와 펜타펩타이드 다이머의 제조방법과 이를 포함하는 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1019528B1 (en) * 1996-01-04 2003-10-29 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for assaying proteolytic enzymes using fluorescence-quenched substrates
AU2002230630A1 (en) * 2000-11-08 2002-05-21 Beth Israel Deaconess Medical Center, Inc. Methods for determining protease cleavage site motifs

Also Published As

Publication number Publication date
AU2003263736A1 (en) 2003-11-11
JP2005538946A (ja) 2005-12-22
EP1504094A2 (en) 2005-02-09
WO2003095475A2 (en) 2003-11-20
CA2485437A1 (en) 2003-11-20
IL165084A0 (en) 2005-12-18
WO2003095475A8 (en) 2004-06-10
MXPA04011142A (es) 2005-02-17
KR20050034642A (ko) 2005-04-14
AU2003263736A2 (en) 2003-11-11
US20040018561A1 (en) 2004-01-29
WO2003095475A3 (en) 2004-08-26
PL374438A1 (en) 2005-10-17

Similar Documents

Publication Publication Date Title
BR0310003A (pt) compostos peptìdeos e seu uso como substratos de protease
Rami et al. Blockade of calpain proteolytic activity rescues neurons from glutamate excitotoxicity
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
NZ596269A (en) Protease screening methods and proteases identified thereby
BRPI0507971A (pt) composto, composição farmacêutica, uso de um composto,método para inibir a atividade proteolìtica de uma enzima de clivagem pós-prolina e remédio empacotado
BRPI0519148A2 (pt) inibidores de homodimerizaÇço de myd88
PT966465E (pt) Inibidores do enzima imfdh
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
BR0112666A (pt) Peptìdeos como inibidores de ns3-serina protease de vìrus da hepatite c
BR9916894A (pt) ácidos sulfohidroxâmicos e sulfohidroxamatos eseu uso como inibidores de mek
NZ533994A (en) Amino alcohol derivative or phosphonic acid derivative and medicinal compostion containing these
BR0108750A (pt) Variantes da xilanase que apresentam sensibilidade alterada para inibidores da xilanase
MX2010004371A (es) Proteasa de streptomyces.
UY30984A1 (es) Proteinas de fusion de formula m-a para degradar péptidos beta amiloides, composiciones en base a ella, preparacion y aplicaciones.
SE0002202D0 (sv) New peptides
TR199902751T2 (xx) Proteaz inhibit�rleri.
BRPI0513267A (pt) variantes melhoradas de aprotinina
BR0306928A (pt) Composições farmacêuticas estáveis compreendendo inibidores de enzimas conversoras de angiotensina (ace)
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
HUP0101899A2 (hu) Cisztein-aktivitástól függő enzimeket gátló hatású tiadiazolvegyületek, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
BR0302496A (pt) Composições farmacêuticas com atividade antibiótica
AR030718A1 (es) Proteinas de bacillus thuringiensis inhibidoras de insectos fusiones y metodos de uso de las mismas
DE59009945D1 (de) Mittel zur hemmung von hiv-proteasen.
CA2549185A1 (en) Peptide inhibiting angiotensin converting enzyme